Jeffrey M Sobell

Guest Editor for the following articles:

Jun
2014
Vol. 33. No. 4

Therapeutic Development in Psoriasis

Craig L. Leonardi, MD | Jeffrey M Sobell, MD

Advances in molecular biology have provided the basis for development of new therapeutic approaches to psoriasis

MORE
Sep
2018
Vol. 37. No. 3

Ustekinumab for the treatment of psoriasis: an evidence update

Zenas Z N Yiu, MBChB, BSc, MRCP | Richard B. Warren, PhD, MRCP

We review new evidence since ustekinumab was licensed for relative efficacy in comparison with other biologic therapies from head-to-head randomized controlled trials and network meta-analyses for the treatment of psoriasis.

MORE
Sep
2018
Vol. 37. No. 3

IL-17 inhibitors for psoriasis

So Yeon Paek, MD | Jillian Frieder, MD | Dario Kivelevitch, MD | Alan Menter, MD

The role of the Th17/interleukin (IL)-23 pathway has been well elucidated in psoriasis.

MORE